Clinical trial
Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients
NCT00098241 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00098241 |
|---|---|
| Title | Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients |
| Official title | Multicenter Trial of the Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Certican |
| Enrollment | 45 |
| Start date | Jun 1, 2000 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Dec 6, 2004 |
| Last update posted | Feb 23, 2017 |
| Countries | Belgium, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: